Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Early Bird Rates now available >> Secure your pass

Early Bird Rates now available >> Secure your pass

Early Bird Rates now available >> Secure your pass

Early Bird Rates now available >> Secure your pass

Early Bird Rates now available >> Secure your pass

Early Bird Rates now available >> Secure your pass

HPV and Head & Neck Forum

From early detection to survivorship: Advancing care in HPV-related head & neck cancer

Thursday, February 11 • 8.00 • 19.30
Friday, February 12 • 8.00 • 17.45

The EUROGIN HPV and Head & Neck Cancer Forum provides a platform for recent advances and ongoing research in HPV-associated head and neck cancers.

This year’s program encompasses sessions on epidemiology and prevention, screening and treatment trial updates, molecular diagnostics and surveillance, innovations in personalized medicine including those leveraging artificial intelligence, and emerging developments in basic science, survivorship, and recurrent respiratory papillomavirus.

Thursday, February 11

8.00 - 9.30

I. Submitted papers I

9.30 - 11.00

II. Epidemiology and prevention of HPV+ head and neck cancers

14.30 - 16.00

III. Trial updates I: Screening / Early detection / Care delivery

16.30 - 18.00

IV. Trial updates II: Treatment

18.00 - 19.30

V. Submitted papers II

Friday, February 12

8.00 - 9.30

VI. New biological insights into HPV+ OPC

10.00 -11.30

VII. Prognostic modeling and personalized treatment

11.30 - 13.00

VIII. Recurrent and metastatic HPV(+) OPC

14.15 - 15.45

IX. Living well after HPV-associated head and neck cancer: Survivorship and surveillance care delivery

16.15 - 17.45

X. Recurrent Respiratory Papillomatosis – Scientific and clinical updates

Register today

Don't miss out on the the world’s leading international congress on HPV infection and associated cancers.
See you in Bologna, February 10-13, 2027.